Among Ca# + -dependent (C-type) animal lectins, the chicken hepatic lectin (CHL) is unique in displaying almost complete selectivity for N-acetylglucosamine over other monosaccharide ligands. The crystal structures of the carbohydrate-recognition domain (CRD) from serum mannose-binding protein (MBP) and of a complex between the CRD from liver MBP and the methyl glycoside of N-acetylglucosamine were used to model the binding site in CHL. Substitution of portions of CHL into the MBP framework did not substantially increase selectivity. A bacterial expression system for the CRD of CHL was developed
INTRODUCTION
The chicken hepatic lectin (CHL) is an endocytic receptor that can mediate the clearance of serum glycoproteins that terminate in N-acetylglucosamine [1] . The receptor is a simple type II transmembrane protein, with a short N-terminal cytoplasmic domain, a transmembrane signal anchor and a C-terminal extracellular carbohydrate-recognition domain (CRD) [2, 3] . The intact receptor consists of a cluster of polypeptides that is probably a trimer when initially solubilized from the plasma membrane with detergents [4, 5] . The trimer is likely to be stabilized by formation of a coiled coil of α-helices in the transmembrane sequence and the short stalk region that lies between the membrane surface and the CRD [6] . CHL seems to be the avian homologue of the mammalian asialoglycoprotein receptor, which is similar in overall organization but binds to glycoproteins terminating in galactose or N-acetylgalactosamine [7] .
Ligand binding to CHL is dependent on Ca# + ; the C-terminal CRD is homologous with CRDs in other C-type (Ca# + -dependent) animal lectins such as the asialoglycoprotein receptor, soluble mannose-binding proteins (MBPs) and the selectin cell adhesion molecules [7] . The CRDs of this family of molecules are characterized by a series of conserved residues that determine the basic folding of the domain and formation of binding sites for Ca# + . However, the different members of the family display widely different sugar-binding characteristics. The C-type CRDs can be broadly divided into two groups: those that bind mannose, N-acetylglucosamine and related sugars, and those that bind galactose and related sugars [8] . Discrimination between these two groups of carbohydrate ligands is based on the orientation of the 3-and 4-hydroxy groups, which are both equatorial in the first group and are equatorial and axial in the second. Analysis of crystal structures of wild-type and mutant CRDs from MBPs so that specific residues predicted to be near the 2-acetamido substituent of N-acetylglucosamine could be altered by sitedirected mutagenesis. The results indicate that the ligand is bound to CHL in the same orientation as it binds to liver MBP. A tyrosine and a valine residue that probably contact the the Nacetyl group have been identified. These results, together with studies of ligand-binding selectivity, suggest that these residues form part of a binding pocket for the N-acetyl group, which confers selective binding of N-acetylglucosamine.
reveals that these hydroxy groups interact with the CRDs at a conserved Ca# + -binding site, forming direct co-ordination bonds to the Ca# + as well as hydrogen bonds to amino acid side chains [9] .
There are two unusual aspects of the sugar-binding selectivity of CHL compared with other C-type animal lectins. First, sequence alignments, analysis of gene organization and comparison of overall structural architecture all indicate that CHL is evolutionarily most closely related to the mammalian asialoglycoprotein receptor subgroup of C-type lectins, yet its binding specificity is completely different [10, 11] . Secondly, among Ctype animal lectins that bind N-acetylglucosamine, CHL is unique in showing almost complete specificity for this sugar and far weaker affinity for glucose, mannose or -fucose. The first of these properties can be explained by the specific arrangement of ligands around the conserved Ca# + -binding site in CHL. Among the ligands for this Ca# + , two are invariably found to be Glu and Asn in CRDs that bind ligands with equatorial 3-and 4-hydroxy groups, whereas these same positions are always occupied by Gln and Asp in domains that bind galactose and related ligands [12] . In the course of evolution of CHL, these residues have selectively diverged from the corresponding residues in the otherwise largely similar galactose-binding CRDs of the asialoglycoprotein receptor.
The basis for highly selective binding of N-acetylglucosamine to CHL is less easily explained by our current knowledge of Ctype CRD structure. Mutagenesis studies suggest that highaffinity binding of N-acetylgalactosamine to one subunit of the mammalian hepatic asialoglycoprotein receptor reflects additional contacts between the 2-acetamido substituent and the protein surface [13] . To establish a similar relationship for CHL it is necessary to determine the orientation of the sugar in the binding site and then identify residues that make contact with the 2-substituent. A reasonable model for the arrangement of the CHL binding site can be derived from comparison with the structures of MBPs in complex with carbohydrate ligands. Both the structures of the serum protein (MBP-A) and the liver protein (MBP-C) are known [9, 14] . Because the structure of MBP-C in complex with N-acetylglucosamine has been solved it can be used to create a model of the CHL binding site with bound ligand.
Several approaches have been taken to test the picture of ligand-binding to CHL that emerges from such comparisons. Production of chimaeric domains containing portions of MBP-A and CHL failed to indicate which portion of the molecule confers selectivity for N-acetylglucosamine over mannose. A bacterial expression system has been developed for the CHL CRD. An analysis of mutant CRDs produced in this system confirms that N-acetylglucosamine probably binds to CHL in the same way as it binds to MBP-C, but that selectivity is achieved by non-polar contacts of two additional residues with the 2-acetamido substituent of the bound ligand.
EXPERIMENTAL Materials
Man $" -BSA and GlcNAc #) -BSA were obtained from E-Y Laboratories and were iodinated by the method of Greenwood et al. [15] Na"#&I, [$&S]methionine, reagents for translation in itro, Amplify fluorography solution and the Sequenase II kit for DNA sequencing were purchased from Amersham. Anhydrides and glucosamine hydrochloride were obtained from Sigma Chemical Co. Bis(sulphosuccinimidyl) suberate was purchased from Pierce Chemical Co. Synthetic oligonucleotides were prepared on an Applied Biosystems 391 DNA synthesizer.
Synthesis of glucosamine derivatives
N-acetylglucosamine-Sepharose was prepared by the method of Fornstedt and Porath [16] . N-Acyl derivatives of glucosamine were prepared by condensation with anhydrides [17] except for the formyl derivative, which was prepared from the mixed anhydride of formic and acetic acid [18] . After purification on Dowex, reagents were analysed by TLC. Concentrations were determined by the method of Morgan and Ellson after hydrolysis for 3 h at 96 mC in 1 M HCl [19] .
Preparation of expression plasmids
Manipulation of DNA was performed with standard molecular biology methods [20] . For transcription experiments in itro, a fragment of the CHL cDNA [21] was inserted into the polylinker of vector pGIR-199, which contains the signal sequence of preproinsulin in vector pSP64 [22] . For the corresponding bacterial expression construct, the same fragment was inserted into the polylinker of the vector pINIIIompA2 [23] . For the extended bacterial expression construct, a longer fragment was inserted into vector pINIIIompA3 [23] . Chimaeric cDNA species and site-specific mutants were created by combining restriction fragments from wild-type cDNA species and synthetic doublestranded oligonucleotides by following published procedures [20] . All mutations were confirmed by DNA sequencing [24] .
Transcription and translation in vitro
Synthetic mRNA was prepared with SP6 polymerase and isolated by gel-filtration chromatography on a micro scale as previously described [25] . Translation in itro with rabbit reticulocyte lysate in the presence of dog pancreas microsomes was followed by sedimentation of microsomes, which were solubilized and analysed on columns containing immobilized N-acetylglucosamine.
Isolation of CRDs
Isolation of bacterially expressed fragments of CHL involved minor modifications of procedures previously used for related CRDs of C-type animal lectins [26, 27] . Luria-Bertani medium (500 ml) containing 50 µg\ml ampicillin was inoculated with 10 ml of overnight culture of plasmid-containing Escherichia coli strain JA221. After growth to a D &&! of 0.5 (2-3 h), induction was performed by the addition of isopropyl β--thiogalactoside to a concentration of 0.4 mM and CaCl # to a final concentration of 0.1 M. Growth was continued for 3 h, after which cells were harvested by centrifugation at 3660 g for 10 min in the JS-4.3 rotor of a Beckman JA21HC centrifuge. The cell pellet was suspended directly in 50 ml of low-Ca# + loading buffer [1.25 M NaCl\3 mM CaCl # \25 mM Tris\HCl (pH 7.8)] and subjected to eight pulses of sonication with the 4 mm probe of a Branson Model 250 sonifier, with pauses between pulses to allow cooling on ice. Debris was removed by centrifugation for 15 min at 27 000 g in a Beckman JA21 high-speed rotor. The clarified extract was loaded on a 1 ml column of N-acetylglucosamineSepharose that had been prewashed with 5 ml of low-Ca# + loading buffer. The column was rinsed with 2 ml of low-Ca# + loading buffer followed by 5 ml of high-Ca# + loading buffer [1.25 M NaCl\25 mM CaCl # \25 mM Tris\HCl (pH 7.8)] and eluted with 2.5 ml of eluting buffer [1.25 M NaCl\2.5 mM EDTA\25 mM Tris\HCl (pH 7.8)]. Aliquots (25 µl) from fractions of 1 ml collected during washing and 0.5 ml collected during elution were examined by SDS\PAGE. The CRDs of MBP-A and CHL\MBP-A chimaeras were isolated by following the published protocol for MBP-A [27] .
Analytical methods
Protein sequencing was performed on an Applied Biosystems 470A sequencer. SDS\PAGE was performed with the system of Laemmli [28] . Binding assays were performed as previously described for other CRDs, with "#&I-Man $" -BSA and "#&I-GlcNAc #) -BSA as reporter ligands [13, 29] . They were analysed with SigmaPlot to perform non-linear least-squares fitting with the equations previously described [13] . K I is the concentration at which half-maximal inhibition of reporter ligand binding is obtained. Gel-filtration chromatography was performed on an LKB SW3000G column with the following molecular mass standards : ovalbumin (45 kDa), carbonic anhydrase (29 kDa), myoglobin (17 kDa) and aprotinin (6.5 kDa). Cross-linking with bis(sulphosuccinimidyl) suberate and analysis by SDS\PAGE followed published procedures [26, 30] . For NMR experiments, wild-type extracellular domain purified as described in the previous section was rebound to a 1 ml column of Nacetylglucosamine-Sepharose, which was then rinsed with 5 ml of high-Ca# + loading buffer prepared with #H # O and deuterated Tris. Protein was eluted in 15 fractions of 0.25 ml with eluting buffer prepared with #H # O and deuterated Tris. Fractions containing protein, at a concentration of approx. 100 µg\ml, were pooled. Titration with the β-methyl glycoside of N-acetylglucosamine was performed on a Varian Unity 500 MHz spectrometer as previously described [31] .
Molecular modelling
The starting structure of MBP-C was based on co-ordinates deposited in the Protein Database (identifier number pdb1rdn.ent). The program InsightII (BioSym Technologies) was used to change side chains of residues near the sugar-binding site to correspond to the CHL sequence by using the standard rotomer library. No attempt was made to minimize the structure.
RESULTS

Expression of CHL CRD
Definition of a fragment of CHL that contains a functional CRD was undertaken initially by translation in itro of mRNA generated from truncated cDNA templates. Based on the size of other functional CRDs [22] , a fragment corresponding to the C-terminal 145 amino acid residues was tested ( Figure 1 ). To allow proper folding of the CRD in the luminal compartment of the endoplasmic reticulum, the appropriate fragment of the CHL cDNA was fused to the preproinsulin signal sequence and translation was performed in the presence of dog pancreas microsomes [32] . As shown in Figure 2 , sequestration into the microsomes, which was accompanied by signal cleavage and partial glycosylation, resulted in the production of some active CRD that could be retained on an N-acetylglucosamineSepharose column. This result confirmed that the expressed fragment contains the functional CRD, and formed the basis for the development of a bacterial expression system.
The same fragment of the CHL cDNA was inserted into a bacterial expression vector containing the ompA signal sequence [23] . Tests showed that protein immunoreactive with antibodies to CHL and having the expected molecular mass was produced, but attempts to purify it by following protocols that had been successful with other C-type CRDs failed [26, 27] . These approaches included denaturation and renaturation as well as direct induction in the presence of Ca# + (results not shown).
One important difference between CHL and other C-type CRDs is the presence of an extra cysteine residue near the C-terminus of CHL. Based on the disulphide-bonding pattern of other C-type CRDs [11] , the expected pattern of disulphide bonds in CHL is shown in Figure 1 . The remaining cysteine residue might contain a free thiol group or might be blocked with a low-molecular-mass compound, but it is not involved in interchain disulphide bond formation because the unreduced 
Figure 2 Purification of CHL CRD expressed by translation in vitro
Templates for mRNA synthesis were derived from wild-type CHL cDNA (left panel) and from mutant template in which Cys 197 has been changed to Ser (right panel). After translation in vitro, microsome-associated protein was passed over N-acetylglucosamine-Sepharose. Flow-through (F) and wash (W) fractions collected in the presence of Ca 2 + and elution (E) fractions collected in the presence of EDTA were examined by SDS/PAGE followed by fluorography. The predominant bands represent glycosylated (jCHO) and unglycosylated (kCHO) material that has been translocated into microsomes and processed to remove the signal sequence (kSS). protein runs as a monomer on SDS\PAGE (results not shown). One possible explanation for the inability to produce functional CHL in bacteria would be incorrect disulphide bond formation caused by this extra cysteine residue.
To demonstrate that Cys"*( of CHL is not required for the formation of a functional CRD, the in itro expression construct was altered to encode a serine residue at this position. As shown in Figure 2 , this modified template was still able to produce functional CRD that could be purified by affinity chromatography on N-acetylglucosamine-Sepharose. The same mutation was then inserted into the bacterial expression construct. Again, purification after solubilization of inclusion bodies followed by renaturation did not yield active protein. However, induction in the presence of Ca# + followed by sonication to release protein from the periplasmic space resulted in the production of active protein that could be purified on the N-acetylglucosamineSepharose column as a single homogeneous species (Figure 3) . Yields of 1-5 mg per 6 litres of culture were somewhat lower than have been obtained for the expression of other CRDs with the same strategy [27, 33, 34] .
An attempt was made to prepare a larger fragment of CHL corresponding to the entire extracellular domain of the receptor. The extent of this construct is shown diagramatically in Figure 1 . Production of the protein followed the same protocol as for the shorter construct, resulting in similar yields of protein that appeared as a single band of slightly higher apparent molecular mass on SDS\PAGE (Figure 3 ). When the protein was subjected to Edman degradation, a unique N-terminal amino acid sequence was obtained, starting with residue 51 of CHL. Because this site lies within the CHL cDNA and not at the normal site of ompA signal processing [23] , it seems that an alternative site is used by the bacterial signal peptidase. The immediately preceding residues (Ala-Arg-Ile) do not form an ideal cleavage site on the basis of the known rules for cleavage of bacterial signal sequences, but in this instance they function efficiently [35] . As a result of this cleavage, the fragment produced and isolated consists solely of amino acids derived from CHL, with no extraneous amino acids from the bacterial expression construct.
Characterization of expressed CRD
The final expressed protein represents most of the extracellular domain of CHL, because only two residues are missing from the N-terminus. Its physical characteristics were examined by gel filtration and chemical cross-linking. Elution of the CRD from a gel-filtration column was consistent with an apparent molecular mass of 23 kDa (results not shown). Because the calculated molecular mass of the expressed polypeptide is 19 kDa, the gelfiltration result indicates that the domain is probably monomeric. Reaction with the reagent bis(sulphosuccinimidyl) suberate (results not shown) failed to produce evidence of any discrete multimeric species under conditions that have revealed oligomers of other C-type CRDs [26] . Thus the extracellular domain produced in bacteria, like a similar fragment produced in rat fibroblasts [5] , does not contain all of the portions of the CHL polypeptide required to form the stable oligomers characteristic of the intact protein. Additional sequences in the transmembrane domains must be required to stabilize the natural oligomer. The binding properties of the expressed fragment of CHL were examined in a series of binding assays in which the fragment was immobilized in polystyrene wells and probed with "#&I-Nacetylglucosamine-BSA. The ability of a series of monosaccharides to compete for binding was tested as a means of comparing the ligand-binding properties of the expressed fragment with those of the intact receptor. The results, shown in Table 1 , demonstrate that the monosaccharide-binding properties of the intact receptor [3, 36] are accurately reflected in the extracellular domain fragment. N-acetylglucosamine is by far the most effective competitor of any of the natural monosaccharides tested. Galactose does not compete detectably, a finding that is consistent with previous studies showing that equatorial 3-and 4-hydroxy groups are absolute prerequisites for CHL ligands [37] .
Also consistent with previous work is the finding that the nature and disposition of the 2-substituent contributes sub- stantially to the ability of monosaccharides to compete for binding. The equatorial N-acetyl substituent of N-acetylglucosamine must make a substantial positive contribution to binding, because the same substituent in an axial orientation (Nacetylmannosamine) or a hydroxy group in an equatorial orientation (glucose) results in far less effective competition. Changes in the acyl substituent in this position have only a modest effect on binding, suggesting that the binding site can accommodate groups bulkier than acetyl. Longer acyl chains have been found to produce a slight increase the affinity of intact CHL for N-substituted ligands [38] .
Localization of the CHL ligand-binding site
The structures of both MBP-A and MBP-C in complex with sugar ligands are known [9, 14] . Although these domains do not show high selectivity for N-acetylglucosamine, they do bind N-acetylglucosamine approximately as well as mannose [14, 39] . A comparison of CHL and MBP-A is shown in Figure 4 . In previous studies of high-selectivity binding of N-acetylgalactosamine to the hepatic asialoglycoprotein receptor, the formation of chimaeras between this receptor and a macrophage homologue that does not bind N-acetylgalactosamine preferentially was a useful approach to identifying residues that form part of the N-acetylgalactosamine-binding site [13] . A similar approach with the use of chimaeras between CHL and MBP-A was therefore undertaken. The portions of MBP-A that have been substituted are summarized, along with the results of the binding competition studies, in Table 2 . Surprisingly, even the most extensive substitutions of CHL sequences into the MBP-A background did not increase selectivity for Nacetylglucosamine as revealed by the relative abilities of mannose and N-acetylglucosamine to compete for binding to the CRD. Thus this approach did not provide any immediate indication of which regions of CHL might contribute to selective interaction with N-acetylglucosamine. Because the chimaera screens did not reveal a region of CHL able to confer selective binding to N-acetylglucosamine, an alternative approach was necessary. With the recent determination of the crystal structure of MBP-C in complex with N-acetylglucosamine [14] , it became possible to make a relatively well-informed proposal about possible residues that might be near the N-acetyl substituent of N-acetylglucosamine and thus contribute to its ability to compete effectively for binding. A model was created by substituting CHL side chains at corresponding positions of MBP-C. The disposition of side chains that fall within 6 A H (1 A H l 0.1 nm) of any portion of the 2-acetamido group of N-acetylglucosamine are indicated in Figure   5 . As no attempt has been made to adjust the positions of side chains to minimize the energy of the structure, the positions shown must be considered approximate. However, the generous distance constraint used in identifying potential contact residues for the 2-substituent of N-acetylglucosamine should ensure that any potential side chains in the binding site have been identified.
Alanine-scanning mutagenesis
Based on the modelling described in the preceding section, a series of single-site mutations were introduced in the CHL CRD at sites that might interact with the N-acetyl group of N-acetylglucosamine in the binding site. Several criteria were used in selecting candidate amino acids. In the two different orientations of sugars seen in crystals of various ligand complexes with MBP-A and MBP-C, residues corresponding to either Arg"($ or Val"*" make contact with the 2-substituents of the bound sugars, so these were clearly candidates to be tested. Among residues that lie within 6 A H of the 2-acetamido group in the approximate model based on MBP-C, additional candidate residues were those that differ between the MBPs and CHL, because the former do not show preferential binding of N-acetylglucosamine, whereas the latter does. A total of nine residues selected in this way were changed to alanine.
All of the mutants could be prepared by the standard purification scheme with N-acetylglucosamine-Sepharose as the affinity matrix. Preferential interaction with CHL was tested by comparing the ability of mannose and N-acetylglucosamine to compete with "#&I-N-acetylglucosamine-BSA for binding to purified mutant proteins immobilized in polystyrene wells. The results of these experiments are summarized in Table 3 . Four of the mutations did not significantly alter the ability of N-acetylglucosamine to compete for binding, three decreased the relative selectivity for N-acetylglucosamine by a factor of about two, and the remaining two mutations resulted in a loss of selectivity to approx. one-tenth.
One of the changes with the greatest effect is Val"*" Ala. This residue corresponds to position Ile#!( in MBP-A and Val#"# in MBP-C. The latter makes van der Waals contact with the 2-substituents of mannose and N-acetylglucosamine in the MBP-C crystals [14] . In contrast, the change Arg"($ Ala has no significant effect on the ability of N-acetylglucosamine to compete for binding. Residue 173 of CHL corresponds to His")* in MBP-A and Val"*% in MBP-C. The former makes contact with the 2-hydroxy group of mannose in MBP-A because the relative orientation of the sugar is reversed compared with MBP-C [9] . These results indicate that N-acetylglucosamine binds to CHL in the orientation seen in the MBP-C crystals.
Figure 5 Model of CHL binding site based on MBP-C crystal structure
The side chains of residues within 6 AH of any portion of the 2-acetamido group of the bound N-acetylglucosamine are shown. On the basis of the results of alanine-scanning mutagenesis, changing the residues shown in white does not affect selectivity for N-acetylglucosamine over mannose ; residues shown in grey have a less than 2-fold effect on the selectivity ; and residues shown in black decrease the selectivity for N-acetylglucosamine to one-eighth or less. This figure was prepared with MOLSCRIPT [42] .
As would be expected, most other changes at residues near to Arg"($ in CHL (Gly"(% and Phe"(&) have no detectable effect on the interaction with N-acetylglucosamine. Gly"(% was tested, even though it is conserved in CHL and the MBPs, because it would be expected to disrupt the turn at this position. Because the change had no effect, it seems that local distortion of this structure does not affect the interaction with N-acetylglucosamine. The 2-fold effect of the change Asn"(' Ala seems likely to be indirect, as this residue is predicted to be 10 A H or more from the 2-substituent of N-acetylglucosamine.
Of the residues near Val"*", the most profound effect results from the change Tyr"*& Ala. The decrease to less than onetenth in selectivity for N-acetylglucosamine suggests that this residue might make a direct contact with the 2-acetamido group, whereas other nearby residues that have a modest effect on binding might exert their effect indirectly by influencing the position of this key tyrosine residue. The fact that the side chains of the two residues that most strongly affect N-acetylglucosamine binding are located close to each other in space, and are the two residues closest to the 2-acetamido group in the model shown in Figure 5 , provides strong support for the basic features of this model.
Nature of interactions with N-acetyl group
Further experiments were undertaken to probe the nature of the interaction between the key residues at positions 191 and 195 and N-acetylglucosamine. A double mutant in which both of these residues are changed to alanine shows less than 2-fold selectivity for N-acetylglucosamine over mannose (Table 3 ). This result indicates that the Val"*" and Tyr"*& side chains probably each interact directly with the 2-substituent of N-acetylglucosamine, because if one acted solely by altering the disposition of the other, no further loss in selectivity would be expected compared with the single-site mutations. Decreased affinity of the double mutant for N-acetylglucosamine is also evident during the chromatographic purification on N-acetylglucosamine-Sepharose, since some elution of this protein is observed during rinsing with Ca# + -containing buffer ( Figure 6 ). Substitution of a phenylalanine residue for tyrosine at position 195 had no significant effect on binding activity, indicating that the interaction with N-acetylglucosamine does not involve the hydroxy group of tyrosine. Thus, rather than involving hydrogen bonding to the polar portions of the 2-acetamido group, the contact with Tyr"*& is more likely to be non-polar. Consistent with this suggestion, substitution of leucine at this position resulted in some increase in selectivity compared with the alanine mutant, but this mutant was still substantially less selective for N-acetylglucosamine than wild-type CHL. The leucine side chain is smaller than the tyrosine side chain and thus probably does not extend far enough to contact the N-acetyl group in the same way.
The structurally best characterized binding site that is selective for N-acetylglucosamine is in a plant lectin, wheat germ agglutinin. A key feature of this binding site is the packing of the methyl portion of the N-acetyl group against the aromatic ring of a tyrosine residue [40] . One of the effects of this packing is a characteristic broadening and shifting of the methyl proton resonances in "H-NMR experiments [41] . However, when a
Figure 6 Purification of mutant CHL CRDs on N-acetylglucosamineSepharose monitored by SDS/PAGE
Protein isolated from a 500 ml culture of bacteria expressing wild-type and mutant CRDs was purified by chromatography on a 1 ml column of N-acetylglucosamine-Sepharose. Fractions were collected at the end of the loading of sample (L ; 1 ml) during washes with Ca 2 + -containing loading buffer (W ; 1 ml each) and during elution with EDTA (E ; 0.5 ml each). Aliquots (25 µl) of each fraction were examined by SDS/PAGE followed by staining with Coomassie Blue. similar experiment was conducted with the wild-type CHL CRD, no selective effect on this part of the sugar spectrum was detected (results not shown). Thus it seems unlikely that the methyl group is orientated directly over the aromatic ring of Tyr"*& ; the hydrophobic contact is more likely to be along the side of the ring.
DISCUSSION
The experiments described provide insight into the organization of the extracellular domain of CHL as well as the mechanism by which it interacts with sugar ligand. Substitution of serine for Cys"*( made it possible to express the extracellular domain in a bacterial system. The fact that this change does not alter the sugar-binding properties of this domain compared with native CHL suggests that Cys"*( does not have a critical role in CHL function and is more likely to have arisen as a neutral evolutionary event.
In principle, the availability of CHL extracellular domain from the bacterial system opens up the possibility of undertaking structural studies on the domain. The fact that the expressed fragment is monomeric is appealing in this regard. However, the poor solubility properties of this fragment and its tendency to aggregate suggest that analysis by either NMR or crystallography will be difficult. For example, although the sharp resonances in the NMR spectrum obtained at 0.1 mM concentration indicate that much of the protein was monomeric during the relatively brief titration experiment, aggregates were evident when the sample was examined by gel electrophoresis after remaining in the spectrometer for 24 h. Similar evidence for aggregation has been obtained in solutions as dilute as 0.5 mg\ml and is has proved to be impossible to redissolve freeze-dried material after repurification by reverse-phase chromatography.
Given the potential difficulty involved in directly obtaining structural information about the sugar-binding site in CHL, molecular modelling based on the known structures of the CRDs of two MBPs, complemented with mutagenesis and binding studies, provides an alternative approach to dissecting the binding site. The results establish that the orientation of N-acetylglucosamine in the binding site of CHL is analogous to the binding of this sugar to MBP-C. In addition, they suggest the presence of a subsite generated by the side chains of Val"*" and Tyr"*& that is responsible for interaction with the N-acetyl substituent through hydrophobic contacts.
It is interesting that the residues observed to be critical for Nacetylglucosamine binding in the alanine-scanning mutagenesis all lie within the portions of CHL that were incorporated into the MBP framework in the chimaeric CRDs, yet none of the chimaeras diplayed a differential affinity for N-acetylglucosamine over mannose. There are several possible explanations for this discrepancy. In one view, differential binding of N-acetylglucosamine in CHL might result from two differences compared with MBP. First, there would be a destabilization of the primary binding contact at the Ca# + site, so that the affinity of CHL for all monosaccharides would be decreased. The interaction with Nacetylglucosamine would then be selectively restored by establishing additional contacts with the 2-acetamido substituent. This proposal is consistent with the finding that N-acetylglucosamine competes for binding to CHL at concentrations similar to those at which N-acetylglucosamine and mannose compete for binding to MBP. In contrast, the liver and macrophage asialoglycoprotein receptors bind to galactose with similar affinities, so that differential binding to N-acetylglucosamine by the liver receptor is achieved only by establishing a much tighter binding to N-acetylglucosamine and other acylated derivatives of galactosamine, with K I values in the micromolar rather than the millimolar range. In this model, the failure of the CHL\MBP-A chimaeric CRDs to bind N-acetylglucosamine preferentially would reflect the fact that additional residues in the CHL framework, which were not incorporated into the chimaeras, must be responsible for subtle changes around the Ca# + site that result in a decreased affinity for most monosaccharides.
Alternatively, a binding pocket for the N-acetyl group might not have been successfully incorporated into the chimaeras because no one construct containing all of the critical residues was created. Attempts to make constructs that included all of the CHL regions shown in Table 2 were unsuccessful, as these were not stable. No construct containing both Val"*" and Tyr"*& was studied, and it is possible that these plus some of the other residues with small and possibly indirect effects must be present together to create the binding pocket.
The available results strongly indicate that the differential affinity for N-acetylglucosamine results from enhanced contacts with the equatorial 2-acetamido group rather than through the exclusion of other sugars. In particular, the lack of binding to glucose and 2-deoxyglucose is difficult to explain by an exclusion mechanism, because these sugars would be smaller than Nacetylglucosamine. In addition, the loss of affinity of the Val"*" Ala\Tyr"*& Ala double mutant for the N-acetylglucosamineSepharose affinity column strongly indicates that contacts with the N-acetyl group are necessary to establish the full affinity of the CHL CRD for its preferred ligand.
